Eloxx Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4.79	0.11	1.13	19.21	42.27
Cash & Short-Term Investments	4.79	0.11	1.13	19.21	42.27
Cash Growth	4210.81%	-90.21%	-94.10%	-54.56%	71.35%
Accounts Receivable	-	2.36	-	-	-
Other Receivables	-	0.36	-	-	-
Receivables	-	2.72	-	-	-
Prepaid Expenses	0.14	0.07	0.15	0.09	0.12
Restricted Cash	0.01	0.01	0.22	0.26	0.3
Other Current Assets	0.34	0.08	0.05	0.57	0.79
Total Current Assets	5.27	2.98	1.55	20.13	43.48
Property, Plant & Equipment	-	-	0.16	0.99	1.66
Total Assets	5.27	2.98	1.71	21.12	45.14
Accounts Payable	2.71	5.35	5.7	3.02	1.38
Accrued Expenses	1.65	2	1.21	2.8	4.2
Short-Term Debt	11.82	13.35	12.97	12.54	3.72
Current Portion of Long-Term Debt	1	6.52	2.22	3.98	-
Current Portion of Leases	-	0	0.13	0.71	0.66
Other Current Liabilities	-	0.1	0.47	0.05	-
Total Current Liabilities	17.18	27.31	22.7	23.09	9.96
Long-Term Debt	-	-	1.61	8.56	12
Long-Term Leases	-	-	0	0.14	0.8
Total Liabilities	17.18	27.31	24.31	31.78	22.76
Common Stock	0.05	0.04	0.03	0.02	0.02
Additional Paid-In Capital	288.63	270.22	268.81	263.71	262.88
Retained Earnings	-300.58	-294.59	-291.44	-274.39	-238.32
Treasury Stock	-	-	-	-	-2.19
Total Common Equity	-11.91	-24.34	-22.6	-10.66	22.38
Shareholders' Equity	-11.91	-24.34	-22.6	-10.66	22.38
Total Liabilities & Equity	5.27	2.98	1.71	21.12	45.14
Total Debt	12.82	19.87	16.93	25.92	17.18
Net Cash (Debt)	-8.03	-19.76	-15.8	-6.71	25.09
Net Cash Growth	-	-	-	-	112.14%
Net Cash Per Share	-3.12	-5.26	-6.15	-3.10	14.34
Filing Date Shares Outstanding	5.07	3.76	2.57	2.17	2.17
Total Common Shares Outstanding	4.79	3.76	2.57	2.17	2.17
Working Capital	-11.91	-24.34	-21.15	-2.96	33.53
Book Value Per Share	-2.49	-6.47	-8.79	-4.92	10.33
Tangible Book Value	-11.91	-24.34	-22.6	-10.66	22.38
Tangible Book Value Per Share	-2.49	-6.47	-8.79	-4.92	10.33
Machinery	-	-	0.26	0.29	0.28
Construction In Progress	-	-	-	-	0.02
Leasehold Improvements	-	-	0.06	0.06	0.09

Updated Nov 13, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.